We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Study Reveals Active and Non-Active Structures of the NMDA Receptor

By LabMedica International staff writers
Posted on 12 May 2016
Print article
Image: A diagram showing how different domains of the NMDA receptor move when the receptor is in active, non-active, and inhibited states. Understanding how NMDA receptors activate is critical in designing novel therapeutic compounds for potential use in schizophrenia, depression, and other disorders (Photo courtesy of Furukawa Lab, Cold Spring Harbor Laboratory).
Image: A diagram showing how different domains of the NMDA receptor move when the receptor is in active, non-active, and inhibited states. Understanding how NMDA receptors activate is critical in designing novel therapeutic compounds for potential use in schizophrenia, depression, and other disorders (Photo courtesy of Furukawa Lab, Cold Spring Harbor Laboratory).
Advanced imaging techniques were used to obtain the three-dimensional structure of the NMDA (N-methyl, D-aspartate) receptor in active and non-active states.

The physiology of N-methyl-d-aspartate (NMDA) receptors is fundamental to brain development and function. NMDA receptors are ionotropic glutamate receptors that function as heterotetramers composed mainly of GluN1 (glycine-binding NMDA receptor subunit 1) and GluN2 (glutamate-binding NMDA receptor subunit 2) subunits. Activation of NMDA receptors requires binding of neurotransmitter agonists to a ligand-binding domain (LBD) and structural rearrangement of an amino-terminal domain (ATD). The membrane domain (TMB) contributes residues to the channel pore and is responsible for the receptor's high-unitary conductance, high-calcium permeability, and voltage-dependent magnesium block.

Previous studies have revealed the structure of the NMDA receptor in an inhibited mode induced by binding of the antagonist compound ifenprodil. Now, investigators at Cold Spring Harbor Laboratory (NY, USA) have used X-ray crystallography, single-particle electron cryomicroscopy (cryoEM), and electrophysiology to establish the structure of rat NMDA receptors in active and non-active mode.

They reported in the May 2, 2016, online edition of the journal Nature that the bi-lobed structure of GluN2 ATD adopted an open conformation accompanied by rearrangement of the GluN1–GluN2 ATD heterodimeric interface. These changes led to additional rotations at various points throughout both the ATD and LBD, causing the ion channel pore to open.

"The NMDA receptor architecture itself is quite complicated," said senior author Dr. Hiro Furukawa, an associate professor at Cold Spring Harbor Laboratory, "but most recently we have been really fascinated by how each of its domains moves in a sophisticated but organized manner. With the technology available today, we do not see continuous movement but instead we see snapshots of NMDA receptors in different functional states."

"Unless we have a library of molecular structures, people in the field will not be able to run those simulations," said Dr. Furukawa. "We hope that this new finding will help pharmacologists come up with better therapeutic compounds that have minimal side effects."

Related Links:
Cold Spring Harbor Laboratory

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.